Clinical Trial Update: A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C [Phase 3]

View source ↗

Summary

A pivotal Phase 3 trial evaluating N-Acetyl-L-Leucine for Niemann-Pick disease type C is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Niemann-pick Disease Type

Drugs mentioned

• N-Acetyl-L-Leucine (N-acetyl-L-leucine)

Snippet

Sponsor: IntraBio Inc | Conditions: Niemann-Pick Disease, Type C | Phase 3 | Status: RECRUITING